Search

Your search keyword '"Roche, Catherine"' showing total 26 results
Start Over Author "Roche, Catherine" Publisher american association for cancer research (aacr)
26 results on '"Roche, Catherine"'

1. A cohort study of CNS tumors in Multiple Endocrine Neoplasia Type 1

Author

Graillon, Thomas, primary, Romanet, Pauline, additional, Camilla, Clara, additional, Gelin, Camille, additional, Appay, Romain, additional, Roche, Catherine, additional, Lagarde, Arnaud, additional, Mougel, Grégory, additional, Farah, Kaissar, additional, Le Bras, Maëlle, additional, Engelhardt, Julien, additional, Kalamarides, Michel, additional, Peyre, Matthieu, additional, Amelot, Aymeric, additional, Emery, Evelyne, additional, Magro, Elsa, additional, Cebula, Helene, additional, Aboukais, Rabih, additional, Bauters, Catherine, additional, Jouanneau, Emmanuel, additional, Berhouma, Moncef, additional, Cuny, Thomas, additional, Dufour, Henry, additional, Loiseau, Hugues, additional, Figarella-Branger, Dominique, additional, Bauchet, Luc, additional, Binquet, CHRISTINE, additional, Barlier, Anne, additional, and Goudet, Pierre, additional

Published
2024
Full Text
View/download PDF

2. Figure S2 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

3. Figure S1 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

4. Figure S3 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

5. Figure S2 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

6. Table S2 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

7. Figure S1 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

8. Figure S4 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

9. Figure S3 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

10. Table S4 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

11. Table S1 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

12. Table S4 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

13. Table S3 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

14. Table S2 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

15. Table S3 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

16. Table S1 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, primary, Campello, Chantal, primary, Idbaih, Ahmed, primary, Peyre, Matthieu, primary, Peyrière, Hadrien, primary, Basset, Noémie, primary, Autran, Didier, primary, Roche, Catherine, primary, Kalamarides, Michel, primary, Roche, Pierre-Hugues, primary, Fuentes, Stéphane, primary, Tabouret, Emeline, primary, Barrie, Maryline, primary, Cohen, Anita, primary, Honoré, Stéphane, primary, Boucekine, Mohamed, primary, Baumstarck, Karine, primary, Figarella-Branger, Dominique, primary, Barlier, Anne, primary, Dufour, Henry, primary, and Chinot, Olivier Louis, primary

Published
2023
Full Text
View/download PDF

17. Data from Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas

Author

Acunzo, Julie, primary, Thirion, Sylvie, primary, Roche, Catherine, primary, Saveanu, Alexandru, primary, Gunz, Ginette, primary, Germanetti, Anne Laure, primary, Couderc, Bettina, primary, Cohen, Richard, primary, Figarella-Branger, Dominique, primary, Dufour, Henry, primary, Brue, Thierry, primary, Enjalbert, Alain, primary, and Barlier, Anne, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure 1 from Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas

Author

Acunzo, Julie, primary, Thirion, Sylvie, primary, Roche, Catherine, primary, Saveanu, Alexandru, primary, Gunz, Ginette, primary, Germanetti, Anne Laure, primary, Couderc, Bettina, primary, Cohen, Richard, primary, Figarella-Branger, Dominique, primary, Dufour, Henry, primary, Brue, Thierry, primary, Enjalbert, Alain, primary, and Barlier, Anne, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figure 2 from Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas

Author

Acunzo, Julie, primary, Thirion, Sylvie, primary, Roche, Catherine, primary, Saveanu, Alexandru, primary, Gunz, Ginette, primary, Germanetti, Anne Laure, primary, Couderc, Bettina, primary, Cohen, Richard, primary, Figarella-Branger, Dominique, primary, Dufour, Henry, primary, Brue, Thierry, primary, Enjalbert, Alain, primary, and Barlier, Anne, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure 2 from Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas

Author

Acunzo, Julie, primary, Thirion, Sylvie, primary, Roche, Catherine, primary, Saveanu, Alexandru, primary, Gunz, Ginette, primary, Germanetti, Anne Laure, primary, Couderc, Bettina, primary, Cohen, Richard, primary, Figarella-Branger, Dominique, primary, Dufour, Henry, primary, Brue, Thierry, primary, Enjalbert, Alain, primary, and Barlier, Anne, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure Legends 1-2 from Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas

Author

Acunzo, Julie, primary, Thirion, Sylvie, primary, Roche, Catherine, primary, Saveanu, Alexandru, primary, Gunz, Ginette, primary, Germanetti, Anne Laure, primary, Couderc, Bettina, primary, Cohen, Richard, primary, Figarella-Branger, Dominique, primary, Dufour, Henry, primary, Brue, Thierry, primary, Enjalbert, Alain, primary, and Barlier, Anne, primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figure Legends 1-2 from Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas

Author

Acunzo, Julie, primary, Thirion, Sylvie, primary, Roche, Catherine, primary, Saveanu, Alexandru, primary, Gunz, Ginette, primary, Germanetti, Anne Laure, primary, Couderc, Bettina, primary, Cohen, Richard, primary, Figarella-Branger, Dominique, primary, Dufour, Henry, primary, Brue, Thierry, primary, Enjalbert, Alain, primary, and Barlier, Anne, primary

Published
2023
Full Text
View/download PDF

23. Data from Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas

Author

Acunzo, Julie, primary, Thirion, Sylvie, primary, Roche, Catherine, primary, Saveanu, Alexandru, primary, Gunz, Ginette, primary, Germanetti, Anne Laure, primary, Couderc, Bettina, primary, Cohen, Richard, primary, Figarella-Branger, Dominique, primary, Dufour, Henry, primary, Brue, Thierry, primary, Enjalbert, Alain, primary, and Barlier, Anne, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure 1 from Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas

Author

Acunzo, Julie, primary, Thirion, Sylvie, primary, Roche, Catherine, primary, Saveanu, Alexandru, primary, Gunz, Ginette, primary, Germanetti, Anne Laure, primary, Couderc, Bettina, primary, Cohen, Richard, primary, Figarella-Branger, Dominique, primary, Dufour, Henry, primary, Brue, Thierry, primary, Enjalbert, Alain, primary, and Barlier, Anne, primary

Published
2023
Full Text
View/download PDF

25. Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Author

Graillon, Thomas, primary, Sanson, Marc, additional, Campello, Chantal, additional, Idbaih, Ahmed, additional, Peyre, Matthieu, additional, Peyrière, Hadrien, additional, Basset, Noémie, additional, Autran, Didier, additional, Roche, Catherine, additional, Kalamarides, Michel, additional, Roche, Pierre-Hugues, additional, Fuentes, Stéphane, additional, Tabouret, Emeline, additional, Barrie, Maryline, additional, Cohen, Anita, additional, Honoré, Stéphane, additional, Boucekine, Mohamed, additional, Baumstarck, Karine, additional, Figarella-Branger, Dominique, additional, Barlier, Anne, additional, Dufour, Henry, additional, and Chinot, Olivier Louis, additional

Published
2020
Full Text
View/download PDF

26. Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas

Author

Acunzo, Julie, primary, Thirion, Sylvie, additional, Roche, Catherine, additional, Saveanu, Alexandru, additional, Gunz, Ginette, additional, Germanetti, Anne Laure, additional, Couderc, Bettina, additional, Cohen, Richard, additional, Figarella-Branger, Dominique, additional, Dufour, Henry, additional, Brue, Thierry, additional, Enjalbert, Alain, additional, and Barlier, Anne, additional

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results